Anti-Trop2/CD3 Bispecific Antibody (Biotech)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameAnti-Trop2/CD3 Bispecific Antibody (Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Trop-2Anti-CD3
TargetsTumor-associated calcium signal transducer 2T cell surface glycoprotein CD3
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBiotech Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiotech Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A